Christina Arevalo, MS

A Phase 3, Multicenter Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Olanzapine/Samidorphan in Patients With Schizophrenia

Background: ALKS 3831, a combination of olanzapine and samidorphan (OLZ/SAM), is in development for the treatment of schizophrenia and is intended to provide the antipsychotic efficacy of...

Christina Arevalo , MS;

Sergey Yagoda , PhD, MD;

Christine Graham , PhD;

Yangsong Cheng , PhD;

Adam Simmons , MPH;

David McDonnell , MD;

11/22/2019

Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Illness: Results of the ENLIGHTEN-Early Study

Abstract: Aims: This 12-week, phase 3, multicenter, double-blind study (NCT03187769) evaluated the effect of combination olanzapine and samidorphan (OLZ/SAM) vs olanzapine on weight in ea...

Christina Arevalo , MS;

01/19/2023